NDC 70257-412

Lyvispah

Baclofen

Lyvispah is a Oral Granule in the Human Prescription Drug category. It is labeled and distributed by Saol Therapeutics Inc. The primary component is Baclofen.

• Product ID: 70257-412_c2cbebf8-e2d6-4515-adbe-c3f7e5091a1b
• NDC: 70257-412
• Product Type: Human Prescription Drug
• Proprietary Name: Lyvispah
• Generic Name: Baclofen
• Dosage Form: Granule
• Route of Administration: ORAL
• Marketing Start Date: 2021-11-22
• Marketing Category: NDA /
• Application Number: NDA215422
• Labeler Name: Saol Therapeutics Inc
• Substance Name: BACLOFEN
• Active Ingredient Strength: 5 mg/1
• Pharm Classes: GABA A Agonists [MoA],GABA B Agonists [MoA],gamma-Aminobutyric Acid-ergic Agonist [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 70257-412-87

90 PACKET in 1 BOTTLE, UNIT-DOSE (70257-412-87) > 1 GRANULE in 1 PACKET

• Marketing Start Date: 2021-11-22
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Lyvispah" or generic name "Baclofen"

NDC	Brand Name	Generic Name
0115-1010	Baclofen	Baclofen
0115-1011	Baclofen	Baclofen
0115-1012	Baclofen	Baclofen
0172-4096	Baclofen	Baclofen
0172-4097	Baclofen	Baclofen
0527-1330	Baclofen	baclofen
0527-1333	Baclofen	baclofen
0527-1337	Baclofen	baclofen
0603-2406	Baclofen	Baclofen
0603-2407	Baclofen	Baclofen
0615-3541	Baclofen	Baclofen
0615-3542	Baclofen	Baclofen
0615-8411	Baclofen	Baclofen
0615-8412	Baclofen	Baclofen